Zymeworks: Overview of Leading ADC Platforms
Antibody-drug conjugates (ADCs) are a class of biotherapeutic drugs targeting cancer, combining the targeting capability of monoclonal antibodies (mAbs) with the anticancer efficacy of cytotoxic drugs (Payload). The antibody and payload are linked by a linker, allowing specific drugs to be delivered to cancer cells targeted by the antibody. Once inside the cell, the linked … Read more